Published in Psychoneuroendocrinology on January 01, 1986
Increased cortisol awakening response and afternoon/evening cortisol output in healthy young adults with low early life parental care. Psychopharmacology (Berl) (2010) 0.91
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry (1991) 8.37
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (1988) 6.12
Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature (2003) 5.84
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82
Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group. Lancet (1999) 4.54
Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis (2000) 4.35
Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res (1995) 4.17
Coming to terms with the terms of risk. Arch Gen Psychiatry (1997) 3.98
Handheld cellular telephone use and risk of brain cancer. JAMA (2000) 3.59
Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI) Sleep (1991) 3.43
Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Arch Gen Psychiatry (1988) 3.32
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry (1997) 3.15
The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). Psychophysiology (2001) 3.15
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med (1983) 2.78
Discrepancies in tuberculin skin test results with two commercial products in a population of intravenous drug users. J Infect Dis (1993) 2.77
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry (2001) 2.70
Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry (1990) 2.66
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol (1992) 2.64
pop-1 encodes an HMG box protein required for the specification of a mesoderm precursor in early C. elegans embryos. Cell (1995) 2.61
PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry (1999) 2.48
The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis (1998) 2.46
Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab (1996) 2.44
Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord (1997) 2.30
Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA (1998) 2.27
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ (1996) 2.27
Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry (1995) 2.23
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet (1996) 2.16
Production of cloned pigs from in vitro systems. Nat Biotechnol (2000) 2.15
Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry (1997) 2.10
The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med (1994) 2.08
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry (2000) 2.06
A dual-radioisotope technique for the evaluation of penile blood flow during tumescence. J Nucl Med (1992) 2.04
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol (1994) 2.03
Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update (2003) 2.02
Screening for anxiety and depression in early adolescence. J Am Acad Child Adolesc Psychiatry (2001) 2.00
Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol (1985) 1.92
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry (2000) 1.91
Competence of depressed patients for consent to research. Am J Psychiatry (1999) 1.91
Sleep-wake disorders based on a polysomnographic diagnosis. A national cooperative study. JAMA (1982) 1.90
Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry (2001) 1.88
Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry (1999) 1.85
Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics (2000) 1.85
The pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO J (1998) 1.83
Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res (2001) 1.82
Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry (2001) 1.81
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol (1994) 1.76
Aminopyridine block of transient potassium current. J Gen Physiol (1982) 1.73
Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest (1991) 1.71
Sleep stage physiology, mood, and vigilance responses to total sleep deprivation in healthy 80-year-olds and 20-year-olds. Psychophysiology (1990) 1.71
Autonomic reactivity and psychopathology in middle childhood. Br J Psychiatry (2001) 1.68
Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. Arch Gen Psychiatry (1991) 1.65
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res (1997) 1.63
The Pittsburgh Sleep Diary. J Sleep Res (1994) 1.62
Towards a genetic dissection of the basis of triplet decoding, and its natural subversion: programmed reading frame shifts and hops. Annu Rev Genet (1991) 1.62
Symptoms of stress and depression as correlates of sleep in primary insomnia. Psychosom Med (2000) 1.61
Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch Gen Psychiatry (1998) 1.59
The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci U S A (1994) 1.57
Exactly what does the Hamilton Depression Rating Scale measure? J Psychiatr Res (1994) 1.56
Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 1.54
The Social Rhythm Metric. An instrument to quantify the daily rhythms of life. J Nerv Ment Dis (1990) 1.53
Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol (1995) 1.53
The nucleotide sequence of the first externally suppressible--1 frameshift mutant, and of some nearby leaky frameshift mutants. EMBO J (1983) 1.52
Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav (2006) 1.51
Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry (1999) 1.50
Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med (2010) 1.49
Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections. Microb Pathog (1988) 1.48
Pattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity. Br J Psychiatry (2013) 1.48
Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J (2001) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Forebrain activation in REM sleep: an FDG PET study. Brain Res (1997) 1.46
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology (2000) 1.45
Assessing the needs of breast cancer patients and their families. Qual Manag Health Care (1993) 1.43
Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer (1997) 1.42
Stimulus equivalence and rule following. J Exp Anal Behav (1989) 1.41
Sleep and morningness-eveningness in the 'middle' years of life (20-59 y). J Sleep Res (1997) 1.40
Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry (2000) 1.39
Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychol Med (1999) 1.39
Science's great tragedy. Aust N Z J Public Health (1998) 1.39
On preserving the National Institute of Mental Health Career Scientist Award. Arch Gen Psychiatry (1998) 1.39
Influence of traumatic grief on suicidal ideation among young adults. Am J Psychiatry (1999) 1.38
Are herbal teas safe for infants and children? Aust Fam Physician (1989) 1.38
Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough. EMBO J (1987) 1.36
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer Chemother Pharmacol (1989) 1.36
Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression. Am J Psychiatry (2000) 1.35
Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychol Med (2003) 1.35
Contributions of risk-factor research to developmental psychopathology. Clin Psychol Rev (1997) 1.34
Validation of a Hamilton subscale for endogenomorphic depression. J Affect Disord (1983) 1.33